Skip to main content
Clinical Trials/NCT04601103
NCT04601103
Terminated
Not Applicable

3M Oral Rinse Evaluation of Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes

Solventum US LLC1 site in 1 country53 target enrollmentJanuary 6, 2020

Overview

Phase
Not Applicable
Intervention
Anti-plaque
Conditions
Oral Mucosal Disorder
Sponsor
Solventum US LLC
Enrollment
53
Locations
1
Primary Endpoint
Number of Participants With Oral Mucosal Exfoliation (Oral Sloughing)
Status
Terminated
Last Updated
last year

Overview

Brief Summary

The primary objective of this study is to evaluate the incidence of oral tissue sloughing through self-report by study subjects and by professional dental examinations.

Detailed Description

The primary objective of this study is to evaluate the incidence of oral tissue sloughing through self-report by study subjects and by professional dental examinations. Adverse events will be tracked through study dental examinations and subject diaries with twice daily use of the 3M Oral Rinse used in combination with toothpaste containing one of three levels (no, medium, high) of Sodium Lauryl Sulfate (SLS). Determine the subjects' acceptance of sloughing and/or other side effects

Registry
clinicaltrials.gov
Start Date
January 6, 2020
End Date
March 10, 2020
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • A member of the Medical Clinical Affairs (MCA) staff or Panda product team for the device under investigation;
  • Have a dental appointment scheduled during study duration for professional cleaning;
  • Is pregnant, nursing, or planning to become pregnant within the study duration;
  • History of antibiotic therapy within the previous 30 days or have a condition that is likely to need antibiotic treatment over the course of the study (e.g., cardiac conditions requiring antibiotic prophylaxis such as heart murmurs, pacemakers, or prosthetic heart valves and prosthetic implants);
  • History of using a prescription antimicrobial mouth rinse during the past 3 months;
  • Currently taking medications which may alter gingival appearance/bleeding;
  • Currently using anticonvulsants, calcium channel blockers, or other medications with side effects known to impact oral health;
  • Participation in any other clinical study within the last 30 days;
  • Resides in the same household with a subject already enrolled in the study;
  • Known history of sensitivity to oral hygiene products;

Arms & Interventions

Comparator: No SLS Toothpaste

3M Oral Rinse in combination with no SLS toothpaste (A)

Intervention: Anti-plaque

Comparator: No SLS Toothpaste

3M Oral Rinse in combination with no SLS toothpaste (A)

Intervention: No SLS toothpaste

Comparator: Medium SLS Toothpaste

3M Oral Rinse in combination with medium SLS toothpaste (B)

Intervention: Medium SLS toothpaste

Comparator: Medium SLS Toothpaste

3M Oral Rinse in combination with medium SLS toothpaste (B)

Intervention: Anti-plaque

Comparator: High SLS Toothpaste

3M Oral Rinse in combination with high SLS toothpaste (C)

Intervention: High SLS toothpaste

Comparator: High SLS Toothpaste

3M Oral Rinse in combination with high SLS toothpaste (C)

Intervention: Anti-plaque

Outcomes

Primary Outcomes

Number of Participants With Oral Mucosal Exfoliation (Oral Sloughing)

Time Frame: End of treatment (3 weeks)

Percentage of participants who experienced oral sloughing as reported either by the subject or determined by the dental evaluator.

Secondary Outcomes

  • The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores(Mid-Treatment (10 days))
  • The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores.(End of Treatment (3 weeks))

Study Sites (1)

Loading locations...

Similar Trials